Page last updated: 2024-10-25

cilostazol and Cirrhoses, Experimental Liver

cilostazol has been researched along with Cirrhoses, Experimental Liver in 1 studies

Research Excerpts

ExcerptRelevanceReference
"All three antiplatelet drugs, namely aspirin, ticlopidine and cilostazol, significantly attenuated liver steatosis, inflammation and fibrosis in the CDAA diet group."3.74Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. ( Abe, Y; Endo, H; Fujita, K; Inamori, M; Iwasaki, T; Kirikoshi, H; Kobayashi, N; Kubota, K; Nagashima, Y; Nakajima, A; Nozaki, Y; Saito, S; Takahashi, H; Wada, K; Yoneda, M, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, K1
Nozaki, Y1
Wada, K1
Yoneda, M1
Endo, H1
Takahashi, H1
Iwasaki, T1
Inamori, M1
Abe, Y1
Kobayashi, N1
Kirikoshi, H1
Kubota, K1
Saito, S1
Nagashima, Y1
Nakajima, A1

Other Studies

1 other study available for cilostazol and Cirrhoses, Experimental Liver

ArticleYear
Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease.
    Gut, 2008, Volume: 57, Issue:11

    Topics: Alanine Transaminase; Animals; Aspirin; Cholesterol; Choline Deficiency; Cilostazol; Dietary Fats; D

2008